NCT02996708

Brief Summary

The purpose of this study is to determine whether Teleconsultation would a)be effective and cost-effective by increasing the proportion of patients with Autism Spectrum Disorders having a correct follow-up, and less transportation, and b) get a high satisfaction from the parents and from the professionals

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
102

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jan 2014

Longer than P75 for all trials

Geographic Reach
1 country

6 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2014

Completed
3 years until next milestone

First Submitted

Initial submission to the registry

December 15, 2016

Completed
4 days until next milestone

First Posted

Study publicly available on registry

December 19, 2016

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2017

Completed
Last Updated

December 19, 2016

Status Verified

December 1, 2016

Enrollment Period

3.9 years

First QC Date

December 15, 2016

Last Update Submit

December 15, 2016

Conditions

Keywords

TelemedicineHealth economics

Outcome Measures

Primary Outcomes (1)

  • Composite score: CARS, VABS evaluated once a year and ADI-R at least once in the lifetime

    Score equals 1 if all three evaluations are performed, 0 otherwise

    One year after the start of the "before" period and one year after the start of the "after" period

Study Arms (4)

Group with teleconsultation - before period

Group without teleconsultation - before period

Group with teleconsultation - after period

Group without teleconsultation - after period

Eligibility Criteria

AgeUp to 18 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Residents of medico-social structure accepting children and adolescent with autism disorders

You may qualify if:

  • All residents of medico-social structures accepting children and adolescent with autism disorders

You may not qualify if:

  • Refusal of parents that their child use telemedicine
  • Refusal of parents that their child participate to the research

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (6)

IME notre Ecole

Carrières-sous-Poissy, 78955, France

RECRUITING

Association Agir et Vivre l'Autisme

Chambourcy, 78240, France

RECRUITING

IME Eclair

Collégien, 77090, France

RECRUITING

Association UNI-TEDS

Dammarie-les-Lys, 77190, France

RECRUITING

Hôpital Sainte Anne

Paris, 75014, France

RECRUITING

IME Le Reverdi

Vert-Saint-Denis, 77240, France

RECRUITING

MeSH Terms

Conditions

Autism Spectrum DisorderAutistic Disorder

Condition Hierarchy (Ancestors)

Child Development Disorders, PervasiveNeurodevelopmental DisordersMental Disorders

Study Officials

  • Catherine Doyen, MD

    Hôpital Sainte Anne

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Isabelle Durand-Zaleski, MD, PhD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 15, 2016

First Posted

December 19, 2016

Study Start

January 1, 2014

Primary Completion

December 1, 2017

Study Completion

December 1, 2017

Last Updated

December 19, 2016

Record last verified: 2016-12

Data Sharing

IPD Sharing
Will not share

Locations